Glycemic Response to Momordica Charantia in Type 2 Diabetes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00823953|
Recruitment Status : Withdrawn (IP could not be made available in sufficient quantity for the expected enrollment)
First Posted : January 16, 2009
Last Update Posted : June 12, 2012
Services Hospital, Lahore
University of the Punjab
Information provided by (Responsible Party):
Khadija Irfan Khawaja, Services Hospital, Lahore
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Actual Primary Completion Date :||February 2009|
|Actual Study Completion Date :||February 2009|
Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res Clin Pract. 1998 Jun;40(3):145-51.
Ahmed I, Lakhani MS, Gillett M, John A, Raza H. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract. 2001 Mar;51(3):155-61.